Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review
Dihydroartemisinin (DHA), a first-line antimalarial drug, has demonstrated great anticancer effects in many types of tumors, including liver cancer, glioblastoma, and pancreatic cancer. Due to its abilities to induce programmed cell death (PCD; apoptosis, autophagy and ferroptosis), inhibit tumor me...
Main Authors: | Ka Hong Wong, Donglin Yang, Shanshan Chen, Chengwei He, Meiwan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087622000460 |
Similar Items
-
Manganese-containing polydopamine nanoparticles as theranostic agents for magnetic resonance imaging and photothermal/chemodynamic combined ferroptosis therapy treating gastric cancer
by: Zhian Chen, et al.
Published: (2022-12-01) -
Photo‐facilitated chemodynamic therapeutic agents: Synthesis, mechanisms, and biomedical applications
by: Nan Yang, et al.
Published: (2023-03-01) -
A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
by: Xiao-Xin Yang, et al.
Published: (2022-05-01) -
Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy
by: Danyang Chen, et al.
Published: (2020-04-01) -
Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
by: Yingqi Feng, et al.
Published: (2022-09-01)